{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:59:43Z","timestamp":1780891183324,"version":"3.54.1"},"reference-count":28,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background\/Objectives: Spontaneous bacterial peritonitis (SBP) is a serious complication of decompensated cirrhosis and is associated with acute kidney injury (AKI), organ failure, and death. Intravenous albumin is recommended in SBP because it reduces renal impairment and mortality, particularly in patients at higher risk of circulatory dysfunction and hepatorenal complications. However, the prognostic impact of early albumin administration on clinical outcomes in hospitalized SBP patients remains incompletely characterized in real-world practice. This study aimed to assess the association between early albumin administration and clinical outcomes in patients hospitalized with SBP compared to those without early albumin. Methods: A retrospective cohort study was conducted using the TriNetX US Collaborative Research Network, including adults hospitalized with SBP through February 2026. Patients were divided into those receiving early albumin administration (n = 1248) and those without early albumin (n = 4932) within 24 h of index SBP diagnosis. Propensity score matching (1:1) balanced cohorts (n = 1230 each) for demographics, comorbidities, liver disease severity surrogates, medications, and laboratory values. Relative risks (RR), risk differences (RD), and hazard ratios (HR) were calculated using propensity-matched and Cox proportional hazard models. Results: Early albumin administration was associated with significantly lower all-cause mortality (RR 0.620; 95% CI: 0.441\u20130.871; p = 0.005 at 5 days; RR 0.770; 95% CI: 0.651\u20130.910; p = 0.002 at 90 days). Secondary outcomes showed reduced risks for acute kidney injury (RR 0.654; 95% CI: 0.553\u20130.774; p &lt; 0.001 at 5 days; RR 0.798; 95% CI: 0.706\u20130.903; p &lt; 0.001 at 90 days), hepatorenal syndrome\u2013AKI (RR 0.598; 95% CI: 0.445\u20130.804; p &lt; 0.001 at 5 days; RR 0.756; 95% CI: 0.613\u20130.932; p = 0.009 at 90 days), vasopressor requirement (RR 0.633; 95% CI: 0.489\u20130.820; p &lt; 0.001 at 5 days; RR 0.712; 95% CI: 0.572\u20130.887; p = 0.002 at 30 days), and renal replacement therapy (RR 0.533; 95% CI: 0.324\u20130.878; p = 0.011 at 5 days; RR 0.642; 95% CI: 0.442\u20130.932; p = 0.019 at 30 days). Cox models confirmed statistically significant risk reductions for all primary and secondary outcomes, including ICU admission (HR 0.82; 95% CI: 0.73\u20130.92; p = 0.001) and 30-day readmission (HR 0.84; 95% CI: 0.73\u20130.97; p = 0.015). Associations were strongest in the early period and attenuated over time. Conclusions: Early albumin administration was associated with reduced risks of mortality, AKI, HRS-AKI, and hemodynamic instability in patients hospitalized with SBP, with attenuation over time. These findings support timely implementation of guideline-concordant albumin therapy, although residual confounding cannot be excluded.<\/jats:p>","DOI":"10.3390\/reports9020176","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:32:46Z","timestamp":1780885966000},"page":"176","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Early Albumin Administration with Clinical Outcomes in Patients Hospitalized with Spontaneous Bacterial Peritonitis: A Propensity-Matched Cohort Study"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-2884","authenticated-orcid":false,"given":"Noor","family":"Albusta","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Lahey Hospital and Medical Center, Burlington, MA 01805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdulla","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Isa","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Almarzooq","sequence":"additional","affiliation":[{"name":"Medical Department, Salmaniya Medical Complex, Manama P.O. Box 12, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.gastro.2023.10.016","article-title":"AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review","volume":"166","author":"Abraldes","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute Kidney Injury in Patients with Cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal Syndrome in Cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100785","DOI":"10.1016\/j.jhepr.2023.100785","article-title":"Use of Albumin Infusion for Cirrhosis-Related Complications: An International Position Statement","volume":"5","author":"Bai","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.chest.2024.02.049","article-title":"Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines","volume":"166","author":"Callum","year":"2024","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"168","article-title":"Albumin Utilization in Spontaneous Bacterial Peritonitis","volume":"56","author":"Ebied","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"ref_9","first-page":"e33124","article-title":"Efficacy of Intravenous Albumin for Spontaneous Bacterial Peritonitis Infection Among Patients with Cirrhosis: A Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Batool","year":"2022","journal-title":"Cureus"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tay, P.W.L., Xiao, J., Tan, D.J.H., Ng, C.H., Lye, Y.N., Lim, W.H., Teo, V.X.Y., Heng, R.R.Y., Yeow, M.W.X., and Lum, L.H.W. (2021). An Epidemiological Meta-Analysis on the Worldwide Prevalence, Resistance, and Outcomes of Spontaneous Bacterial Peritonitis in Cirrhosis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.693652"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Abu-Freha, N., Michael, T., Poupko, L., Estis-Deaton, A., Aasla, M., Abu-Freha, O., Etzion, O., and Nesher, L. (2021). Spontaneous Bacterial Peritonitis among Cirrhotic Patients: Prevalence, Clinical Characteristics, and Outcomes. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010227"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ajem.2023.05.015","article-title":"Emergency Medicine Updates: Spontaneous Bacterial Peritonitis","volume":"70","author":"Long","year":"2023","journal-title":"Am. J. Emerg. Med."},{"key":"ref_13","first-page":"80","article-title":"Spontaneous Bacterial Peritonitis: A Prospective Greek Multicenter Study of Its Epidemiology, Microbiology, and Outcomes","volume":"35","author":"Samonakis","year":"2022","journal-title":"Ann. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000518585","article-title":"Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Shift in the Microbial Pattern? A Retrospective Analysis","volume":"29","author":"Pimentel","year":"2022","journal-title":"GE Port. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s10620-023-07867-8","article-title":"Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis","volume":"68","author":"Furey","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/HMER.S369966","article-title":"Clinical, Laboratory and Bacterial Profile of Spontaneous Bacterial Peritonitis in Vietnamese Patients with Liver Cirrhosis","volume":"14","author":"Nguyen","year":"2022","journal-title":"Hepatic Med. Evid. Res."},{"key":"ref_17","first-page":"e76679","article-title":"Spontaneous Bacterial Peritonitis: Etiology, Microbiology, and Clinical Outcomes in Cirrhosis Patients","volume":"16","author":"Deni","year":"2024","journal-title":"Cureus"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Murayama, A., Tajiri, K., Muraishi, N., Hayashi, Y., Minemura, M., Niimi, H., and Yasuda, I. (2025). Spontaneous Bacterial Peritonitis in Advanced Cirrhosis: Diagnosis by Tm Mapping and Inflammatory Profiles of Extracellular Vesicles. J. Clin. Med., 14.","DOI":"10.3390\/jcm14145096"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis","volume":"27","author":"Gupta","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17562848221102679","DOI":"10.1177\/17562848221102679","article-title":"Management of Hepatorenal Syndrome in Liver Cirrhosis: A Recent Update","volume":"15","author":"Bera","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_21","first-page":"741","article-title":"Recent Advances in Pathophysiology, Diagnosis and Management of Hepatorenal Syndrome: A Review","volume":"15","author":"Kiani","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/2050640620910339","article-title":"Albumin: Indications in Chronic Liver Disease","volume":"8","author":"Tufoni","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-Chronic Liver Failure: Definitions, Pathophysiology and Principles of Treatment","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/HEP.0000000000001251","article-title":"Clinical Outcomes and Care for Spontaneous Bacterial Peritonitis: A National Cohort Study","volume":"82","author":"Serper","year":"2025","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical Features and Evolution of Bacterial Infection-Related Acute-on-Chronic Liver Failure","volume":"74","author":"Wong","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/livers2030018","article-title":"Spontaneous Bacterial Peritonitis in Decompensated Liver Cirrhosis\u2014A Literature Review","volume":"2","author":"Huang","year":"2022","journal-title":"Livers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/CCM.0000000000004192","article-title":"Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations","volume":"48","author":"Nanchal","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wang, S., Zhang, Y., Li, X., Feng, J., Gao, Y., and Huang, R. (2025). Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Are Associated with Increased Liver-Related Readmissions in Cirrhosis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1417222"}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/2\/176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:44:07Z","timestamp":1780890247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/2\/176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["reports9020176"],"URL":"https:\/\/doi.org\/10.3390\/reports9020176","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}